Ann Hepatol. 2009 Jul-Sep;8(3):273-4.

Physical activity and nonalcoholic fatty liver disease.

Gutierrez-Grobe Y, Gavilanes-Espinar JG, Méndez-Sánchez N.

Source

Research Liver Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.

Comment on

Hepatology. 2009 Jul;50(1):68-76.

PMID:: 19841513; [PubMed]

Publication Types

Supplemental Content

Related citations

Independent effects of physical activity in patients with nonalcoholic fatty liver disease. [Hepatology. 2009]
Independent effects of physical activity in patients with nonalcoholic fatty liver disease.
St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. Hepatology. 2009 Jul; 50(1):68-76.
Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease. [Med Sci Monit. 2009]
Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease.
Yilmaz Y, Atug O, Yonal O, Duman D, Ozdogan O, Imeryuz N, Kalayci C. Med Sci Monit. 2009 Apr; 15(4):HY1-5.
Review Fatty liver and the metabolic syndrome. [Curr Opin Gastroenterol. 2007]
Review Fatty liver and the metabolic syndrome.
Neuschwander-Tetri BA. Curr Opin Gastroenterol. 2007 Mar; 23(2):193-8.
Review Nonalcoholic fatty liver disease in the pediatric population: a review. [Curr Opin Pediatr. 2005]
Review Nonalcoholic fatty liver disease in the pediatric population: a review.
Wieckowska A, Feldstein AE. Curr Opin Pediatr. 2005 Oct; 17(5):636-41.
End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. [Hum Pathol. 2010]
End-stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program.
Nayak NC, Vasdev N, Saigal S, Soin AS. Hum Pathol. 2010 Mar; 41(3):425-30. Epub 2009 Dec 1.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Physical activity and nonalcoholic fatty liver disease.
Physical activity and nonalcoholic fatty liver disease.
Ann Hepatol. 2009 Jul-Sep ;8(3):273-4.

PubMed
A spontaneous mutation affects programmed cell death during development of the r...
A spontaneous mutation affects programmed cell death during development of the rat eye.
Exp Eye Res. 2005 Mar ;80(3):323-35.

PubMed
Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production.
Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production.
Dermatology. 2005 ;210(1):36-8.

PubMed
An rtt109-independent role for vps75 in transcription-associated nucleosome dyna...
An rtt109-independent role for vps75 in transcription-associated nucleosome dynamics.
Mol Cell Biol. 2009 Aug ;29(15):4220-34. Epub 2009 May 26 .

PubMed
Clinical recognition and diagnosis of Clostridium difficile infection.
Clinical recognition and diagnosis of Clostridium difficile infection.
Clin Infect Dis. 2008 Jan 15 ;46 Suppl 1:S12-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Physical activity and nonalcoholic fatty liver disease.

Source

Comment on

Publication Types

Publication Types

Supplemental Content

Related citations

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information